Previous reports have already indicated that CHST4 was preferentially expressed in HCC, and it may function as a wonderful diagnosis signal for hepatocellular carcinoma (HCC) patient survival, with higher expression predicting shorter time-to-relapse (TTR) and overall survival (OS). This evidence concerns the gene CHST4 and hepatocellular carcinoma.